These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10615003)

  • 1. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery.
    Wendel HP; Jones DW; Gallimore MJ
    Immunopharmacology; 1999 Dec; 45(1-3):141-4. PubMed ID: 10615003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor XII protease domain crystal structure.
    Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
    J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional correlation between kallikrein and factor XII activated in human plasma.
    Briseid K; Hoem NO; Johannesen S; Marthinsen K
    Thromb Res; 1990 Mar; 57(6):945-56. PubMed ID: 1696402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypass.
    Heller W; Gallimore MJ; Hoffmeister HE
    Agents Actions Suppl; 1992; 38 ( Pt 3)():311-6. PubMed ID: 1281380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients.
    Gallimore MJ; Jones DW; Wendel HP
    Thromb Res; 1999 Apr; 94(2):103-9. PubMed ID: 10230895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human platelets induce factor XIIa-mediated contact activation.
    Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
    Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin in cardiopulmonary bypass--effects on the Hageman factor (FXII)--Kallikrein system and blood loss.
    Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):99-104. PubMed ID: 1377956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk.
    Bach J; Endler G; Winkelmann BR; Boehm BO; Maerz W; Mannhalter C; Hellstern P
    J Thromb Haemost; 2008 Feb; 6(2):291-6. PubMed ID: 18021303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site on factor XII required for productive interactions with polyphosphate.
    Shamanaev A; Litvak M; Cheng Q; Ponczek M; Dickeson SK; Smith SA; Morrissey JH; Gailani D
    J Thromb Haemost; 2023 Jun; 21(6):1567-1579. PubMed ID: 36863563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.
    Hardy LJ; Bohinc D; Bane KL; Heal SL; Hethershaw E; Ali M; Palmer-Dench T; Foster R; Longstaff C; Renné T; Stavrou EX; Philippou H
    J Thromb Haemost; 2023 Apr; 21(4):814-827. PubMed ID: 36990522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.